Showing results (11-20 of 526) with videos related to
Sort By:
Pageof 53
Pharmacogenetics|April 1, 1993
Carbonyl (phenone) reductase in human liver: inter-individual variabilityJ M Wong, W Kalow, D Kadar, et al.Canadian Journal of Physiology and Pharmacology|September 1, 1980
Ethnic difference in drug metabolism: debrisoquine 4-hydroxylation in Caucasians and OrientalsW Kalow, S V Otton, D Kadar, et al.Clinical Pharmacology and Therapeutics|October 1, 1976
Amobarbital--a probe of hepatic drug oxidation in manT Inaba, B K Tang, L Endrenyi, et al.Biomedical Mass Spectrometry|October 1, 1982
Simultaneous determination of antipyrine, 4-hydroxyantipyrine, 3-hydroxymethylantipyrine and norantipyrine in urine by gas chromatography chemical ionization mass spectrometryB K Tang, H Uchino, T Inaba, et al.Clinical Pharmacology and Therapeutics|December 1, 1980
Acute and latent leukopenic reaction to antipyrineD Kadar, W KalowCanadian Journal of Physiology and Pharmacology|October 1, 1985
N-Glucosidation of amobarbital in the catG Carro-Ciampi, M Jurima, D Kadar, et al.Clinical Pharmacology and Therapeutics|December 1, 1979
A method for studying drug metabolism in populations: racial differences in amobarbital metabolismW Kalow, B K Tang, D Kadar, et al.Journal of Chromatography|June 24, 1988
Method to determine the enantiomers of ibuprofen from human urine by high-performance liquid chromatographyD A Nicoll-Griffith, T Inaba, B K Tang, et al.Clinical Pharmacology and Therapeutics|June 1, 1991
Caffeine as a metabolic probe: validation of its use for acetylator phenotypingB K Tang, D Kadar, L Qian, et al.Clinical Pharmacology and Therapeutics|November 1, 1975
Salivary excretion of amobarbital in manT Inaba, W KalowPageof 53